Dr. Ken H.Young is currently working as a Professor in the Department of Hematopathology at The University of Texas MD Anderson Cancer Center, USA. Dr. Young has completed his MD in 1984 from Zhejiang University School of Medicine, China. Later, he has received his Ph.D. from University of Lund School of Medicine, Sweden in 1995. Dr. Young’s team is focusing on several types of hematologic malignancies, with special emphasis on pathogenesis of malignant lymphomas, especially diffuse large B-cell lymphoma (DLBCL). The goal of his team is to explore and identify genetic and non-genetic biomarkers, including p53, Myc, pTEN, Mdm2, Arf, Bcl-2, Bcl-6 genes, alone or in combination with other abnormalities in DLBCL, that predict cancer prognosis and susceptibility.